Receptors for SARS-CoV-2 Present in Wide Variety of Human Cells | The Scientist Magazine®
Frontiers | The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective | Scientific Reports
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Nature
ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues | Human Genomics | Full Text
Frontiers | Analysis of ACE2 Gene-Encoded Proteins Across Mammalian Species
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins | PLOS Biology
TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein | Journal of Virology
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - ScienceDirect
Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction | eLife
Cells | Free Full-Text | SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2 | Journal of Virology
Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2
In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin | Scientific Reports
Advances in developing ACE2 derivatives against SARS-CoV-2 - The Lancet Microbe
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins | PLOS Biology
Frontiers | Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?
Frontiers | Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
ACE2 expressing cells | A549 | InvivoGen
Sequence difference of angiotensin-converting enzyme 2 between nonhuman primates affects its binding-affinity with SARS-CoV-2 S receptor binding domain | Biosafety and Health
Human recombinant soluble ACE2 in severe COVID-19 - The Lancet Respiratory Medicine
